These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 20601889)

  • 21. Correlation between the potency of seven potential beta-adrenoceptor blocking drugs and propranolol to decrease heart rate in reserpinized rats and to perturb liposomes prepared from platelet lipids.
    Ondriasova E; Stasko A; Racanská E; Svec P; Ondrias K
    Pharmazie; 1991 Dec; 46(12):889-90. PubMed ID: 1687834
    [No Abstract]   [Full Text] [Related]  

  • 22. Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenolol.
    Blue DR; Bond RA; Adham N; Delmendo R; Michel AD; Eglen RM; Whiting RL; Clarke DE
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1034-42. PubMed ID: 1969469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stereostructure-based differences in the interactions of cardiotoxic local anesthetics with cholesterol-containing biomimetic membranes.
    Tsuchiya H; Ueno T; Mizogami M
    Bioorg Med Chem; 2011 Jun; 19(11):3410-5. PubMed ID: 21550810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct myocardial depressant effects of several beta-adrenergic blocking agents in the unanesthetized atherosclerotic rabbit.
    Lee RJ; Dickerson DD; Fulmor IE; Goldberg ME
    Proc Soc Exp Biol Med; 1978 Jun; 158(2):147-50. PubMed ID: 27818
    [No Abstract]   [Full Text] [Related]  

  • 25. Some metabolic effects of metipranolol, propranolol, alprenolol, oxprenolol, and practolol in rats.
    Siblíková O; Trcka V
    Acta Univ Carol Med (Praha); 1980; 26(5-6):259-70. PubMed ID: 6126105
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative study of various beta-adrenergic blockers in clinical anesthesiology--alprenolol, oxprenolol, propranolol and LB-46].
    Miyazaki M; Fujita T
    Masui; 1972 Jan; 21(1):1-10. PubMed ID: 4401934
    [No Abstract]   [Full Text] [Related]  

  • 27. Prediction and experimental validation of acute toxicity of beta-blockers in Ceriodaphnia dubia.
    Fraysse B; Garric J
    Environ Toxicol Chem; 2005 Oct; 24(10):2470-6. PubMed ID: 16268148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Permanent effects of postnatal administration of beta-adrenergic ligands on the volume of sexually dimorphic nucleus of the preoptic area (SDN-POA) in rats.
    Izdebska-Straszak G; Gubala E; Jedrzejowska-Szypulka H; Klencki M; Wiczkowski A; Jarzab B
    Neuro Endocrinol Lett; 2006; 27(1-2):105-13. PubMed ID: 16648786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemodynamic, metabolic, and lymphocyte beta 2-adrenoceptor changes following chronic beta-adrenoceptor antagonism.
    Whyte K; Jones CR; Howie CA; Deighton N; Sumner DJ; Reid JL
    Eur J Clin Pharmacol; 1987; 32(3):237-43. PubMed ID: 2885202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further studies regarding the structure activity relationships of beta-adrenoceptor antagonists.
    Bagwell EE; Williams EM
    Br J Pharmacol; 1973 Aug; 48(4):686-92. PubMed ID: 4150921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Iatrogenic dermatoses caused by beta-blocking drugs].
    Alinovi A; Branchetti A; Barella PA
    G Ital Dermatol Venereol; 1983; 118(6):341-8. PubMed ID: 6143722
    [No Abstract]   [Full Text] [Related]  

  • 32. Biophysical characterization of the drug-membrane interactions: the case of propranolol and acebutolol.
    Pereira-Leite C; Carneiro C; Soares JX; Afonso C; Nunes C; Lúcio M; Reis S
    Eur J Pharm Biopharm; 2013 May; 84(1):183-91. PubMed ID: 23291047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiaggregatory Properties of Beta-adrenoceptor Blocking Drugs are Related to their Physico-chemical Properties.
    Nosál R; Jancinová V; Petriková M
    Platelets; 1992; 3(1):29-33. PubMed ID: 21043897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subsidiary class III effects of beta blockers? A comparison of atenolol, metoprolol, nadolol, oxprenolol and sotalol.
    Manley BS; Alexopoulos D; Robinson GJ; Cobbe SM
    Cardiovasc Res; 1986 Oct; 20(10):705-9. PubMed ID: 2878723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of synaptosomal [3H]noradrenaline uptake by beta-adrenoceptor blocking drugs: influence of lipophilicity.
    Street JA; Walsh A
    Eur J Pharmacol; 1984 Jul; 102(2):315-24. PubMed ID: 6148250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Certain beta-blockers can decrease beta-adrenergic receptor number: II. Down-regulation of receptor number by alprenolol and propranolol in cultured lymphoma and muscle cells.
    Hughes RJ; Mahan LC; Insel PA
    Circ Res; 1988 Aug; 63(2):279-85. PubMed ID: 2899462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of beta adrenoceptor blocking drugs on the integrity of rat platelets as measured by 51Cr liberation.
    Turcáni P; Nosál R
    Thromb Res; 1981 Jul 1-15; 23(1-2):187-91. PubMed ID: 6117953
    [No Abstract]   [Full Text] [Related]  

  • 38. Interaction of metoprolol, propranolol and atenolol with concurrent administration of cimetidine.
    Kirch W; Spahn H; Köhler H; Ohnhaus EE; Mutschler E
    Klin Wochenschr; 1982 Nov; 60(22):1401-7. PubMed ID: 7176462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-adrenoceptor antagonists and human sperm motility.
    Curtis-Prior PB; Gadd AL
    J Pharm Pharmacol; 1990 Mar; 42(3):220-2. PubMed ID: 1974626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ventilatory response to hypercapnia in normal subjects after propranolol, metoprolol and oxprenolol.
    Folgering H; Braakhekke J
    Respiration; 1980; 39(3):139-43. PubMed ID: 6773123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.